ABBV · AbbVie Inc. · Investor Relations
$295.03
+0.58 (+0.20%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$521.50B
Shares
1.77B
Volume · Nov 13
3.26M
Avg daily vol (3M)
4.8M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-10-30 | AbbVie Reports Third-Quarter 2026 Financial Results |
| 2026-09-03 | AbbVie Completes Acquisition of Apogee Therapeutics |
| 2026-07-31 | AbbVie Reports Second-Quarter 2026 Financial Results |
| 2026-06-22 | AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio |
| 2026-04-29 | AbbVie Reports First-Quarter 2026 Financial Results |
| 2026-02-04 | AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results |
Past events
Source: https://investors.abbvie.com/
Key facts
CIK
1551152
CUSIP
00287Y109
13F (30d)
3367 filings
3202 filers
Visit website
Investor relations